💊Licensing Opportunities for RXFP1 Agonists by NIH
Government Owned Inventions Available for Licensing or Collaboration: RFXP1 AGONISTS
Summary
The National Center for Advancing Translational Sciences (NCATS), an institute of the National Institutes of Health (NIH), Department of Health and Human Services (HHS), is giving notice of the licensing opportunities for the inventions listed below, which are owned by an agency of the U.S. Government, Florida International University (FIU), and University of South Florida (USF). The NCATS has taken the lead in both patenting and licensing via consolidation of rights under an Inter Institutional Agreement (IIA). The inventions are available for licensing and collaboration to achieve expeditious commercialization results of federally funded research and development.
Agencies
- Health and Human Services Department
- National Institutes of Health
Business Impact
$$$ - High
The notice outlines licensing opportunities for government-owned inventions, specifically RXFP1 agonists, which can lead to potential partnerships and commercialization projects for businesses in the biotech and pharmaceutical sectors. This is particularly relevant for companies seeking innovative therapeutic solutions.